Frontier Capital Management’s Sangamo Therapeutics SGMO Stock Holding History

Frontier Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-178,136	Closed	-$2.78M	–	300
2020 Q4	$2.78M	Sell	178,136 -23,586	-12%	-$368K	0.02%	275
2020 Q3	$1.91M	Sell	201,722 -17,152	-8%	-$162K	0.02%	281
2020 Q2	$1.96M	Sell	218,874 -24,798	-10%	-$222K	0.02%	282
2020 Q1	$1.55M	Sell	243,672 -5,287	-2%	-$33.7K	0.02%	266
2019 Q4	$2.08M	Sell	248,959 -25,949	-9%	-$217K	0.02%	268
2019 Q3	$2.49M	Sell	274,908 -19,540	-7%	-$177K	0.02%	267
2019 Q2	$3.17M	Sell	294,448 -120,808	-29%	-$1.3M	0.02%	274
2019 Q1	$3.96M	Sell	415,256 -28,130	-6%	-$268K	0.03%	271
2018 Q4	$5.09M	Sell	443,386 -7,770	-2%	-$89.2K	0.04%	260
2018 Q3	$7.65M	Sell	451,156 -16,225	-3%	-$275K	0.05%	253
2018 Q2	$6.64M	Sell	467,381 -8,007	-2%	-$114K	0.05%	254
2018 Q1	$9.03M	Sell	475,388 -2,338	-0.5%	-$44.4K	0.07%	244
2017 Q4	$7.84M	Sell	477,726 -10,062	-2%	-$165K	0.06%	241
2017 Q3	$7.32M	Sell	487,788 -7,240	-1%	-$109K	0.05%	253
2017 Q2	$4.36M	Sell	495,028 -4,775	-1%	-$42K	0.03%	273
2017 Q1	$2.6M	Sell	499,803 -9,329	-2%	-$48.5K	0.02%	282
2016 Q4	$1.55M	Sell	509,132 -4,944	-1%	-$15.1K	0.01%	278
2016 Q3	$2.38M	Buy	514,076 +146	+0%	+$676	0.02%	283
2016 Q2	$2.98M	Sell	513,930 -313,637	-38%	-$1.82M	0.02%	279
2016 Q1	$5.01M	Sell	827,567 -2,084	-0.3%	-$12.6K	0.04%	270
2015 Q4	$7.58M	Sell	829,651 -253,136	-23%	-$2.31M	0.06%	265
2015 Q3	$6.11M	Sell	1,082,787 -818,817	-43%	-$4.62M	0.05%	274
2015 Q2	$21.1M	Sell	1,901,604 -265,371	-12%	-$2.94M	0.15%	203
2015 Q1	$34M	Buy	2,166,975 +305,417	+16%	+$4.79M	0.25%	154
2014 Q4	$28.3M	Sell	1,861,558 -290,621	-14%	-$4.42M	0.21%	165
2014 Q3	$23.2M	Sell	2,152,179 -70,216	-3%	-$757K	0.19%	179
2014 Q2	$33.9M	Buy	2,222,395 +905,205	+69%	+$13.8M	0.25%	144
2014 Q1	$23.8M	Buy	+1,317,190	New	+$23.8M	0.17%	181